About Jungla
Jungla is a company based in San Francisco (United States) founded in 2016 was acquired by Invitae in July 2019. Jungla has raised $2.75 million across 2 funding rounds from investors including Invitae, Andreessen Horowitz and IndieBio. Jungla operates in a competitive market with competitors including Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Jungla
Unlock access to complete
Advisor Team
4 people
Software Development Team
1 people
Cofounder Team
1 people
Machine Team
1 people
Unlock access to complete
Funding Insights of Jungla
Jungla has successfully raised a total of $2.75M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.5 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Jungla
Jungla has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Invitae, Andreessen Horowitz and IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Locked | Locked | Locked | |
|
Home-based genetic tests for detecting diseases are provided to individuals.
|
Locked | Locked | Locked |
Investor details for Jungla
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jungla
Investment portfolio details for Jungla
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Jungla
Detailed financials for Jungla
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jungla Comparisons
Peer comparison for Jungla
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jungla
Jungla operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Benchling, Genuity Science, Inpharmatica and BioAge Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cloud-based bioinformatics platform is offered for biotech research.
|
|
| Locked | Locked | Locked |
AI-based omics data analysis solutions are provided to researchers.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Bioinformatics platform is provided for biomarkers and drug discovery.
|
|
| Locked | Locked | Locked |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
Detailed competitors of Jungla
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jungla
Complete news archive for Jungla
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jungla
Jungla was founded in 2016.
Jungla is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Jungla is a funded company, having raised a total of $2.75M across 2 funding rounds to date.
Jungla was founded in 2016 in San Francisco, United States. Genomic software solutions are developed by the company within the biotechnology sector. A proprietary platform is employed to model genetic variants and correlate them with disease states via advanced statistical methods. Operations focus on supporting diagnostic development processes across various applications.
Jungla's top competitors include Helix, Benchling and BioAge Labs.
Jungla has 3 investors. Key investors include Invitae, Andreessen Horowitz, and IndieBio.